Clinical Trial Update: Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of epirubicin, cisplatin, and fluorouracil with Endostar in patients with advanced or metastatic gastric cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Endostar (recombinant human endostatin)
• Epirubicin (epirubicin)
• FLUOROURACIL (Fluorouracil)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED